Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran)

PURPOSE OF REVIEW: The aim of low-density lipoprotein-cholesterol (LDL-C) lowering therapies is to safely achieve a consistent and long-term reduction in exposure of the vasculature to atherogenic lipoproteins in order to reduce the risk of atherosclerotic cardiovascular (CV) disease and the associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinning, David, Landmesser, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
New Therapies for Cardiovascular Disease (AA Bavry, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578129/
https://www.ncbi.nlm.nih.gov/pubmed/33089390
http://dx.doi.org/10.1007/s11886-020-01427-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7578129/
https://www.ncbi.nlm.nih.gov/pubmed/33089390
http://dx.doi.org/10.1007/s11886-020-01427-6

Ejemplares similares